TrademarkDir
PARMED PHARMACEUTICALS
LIVE

Serial Number

86921360

Owner

CARDINAL HEALTH 110, LLC

Attorney

N. Christopher Norton

First Use Date

Dec 1, 2015

Filing Date

Feb 26, 2016

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

PARMED PHARMACEUTICALS Trademark

Serial Number: 86921360 • Registration: 5058525

PARMED PHARMACEUTICALS is a trademark filed by CARDINAL HEALTH 110, LLC on February 26, 2016. The trademark is classified under Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

CARDINAL HEALTH 110, LLC (15 trademarks)

7000 CARDINAL PLACE
DUBLIN, OH 43017

Entity Type: 16

Trademark Details

Filing Date

February 26, 2016

Registration Date

October 11, 2016

First Use Anywhere

December 1, 2015

First Use in Commerce

December 1, 2015

Published for Opposition

July 26, 2016

Goods & Services

distributorship services in the field of pharmaceuticals

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Oct 11, 2025 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Dec 30, 2022 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Dec 30, 2022 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 30, 2022 APRE
TEAS SECTION 8 & 15 RECEIVED
Jun 16, 2022 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 11, 2021 REM1
REGISTERED-PRINCIPAL REGISTER
Oct 11, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 26, 2016 NPUB
PUBLISHED FOR OPPOSITION
Jul 26, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 6, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 17, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 17, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 17, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 17, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 17, 2016 CNEA
ASSIGNED TO EXAMINER
Jun 10, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 2, 2016 NWOS
NEW APPLICATION ENTERED
Mar 1, 2016 NWAP

Related Trademarks

More from this Owner

ATRIX

ATRIX

ATRIX

ATRIX

ATRIX

ATRIX

COUNTER TALK

COUNTER TALK

COUNTER TALK

COUNTER TALK

COUNTER TALK

COUNTER TALK